FDA Media Alert Detail

FDA Safety Alert

Ana Salazar Modela Tu Cuerpo Inc. Issues Nationwide Voluntary Recall of Lipofit Extreme Fat Burner 2.0 Due to Presence of Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)

  • U.S. Food and Drug Administration
  • August 31, 2026
  • ID: http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ana-salazar-modela-tu-cuerpo-inc-issues-nationwide-voluntary-recall-lipofit-extreme-fat-burner-20

FDA MedWatch Safety Alert

FOR IMMEDIATE RELEASE - August 27, 2026 - Davie, Florida – Ana Salazar Modela Tu Cuerpo Inc. is recalling Lipofit Extreme Fat Burner 2.0, Lot 25M12F, expiration date 09/2027, to the consumer level. The Food and Drug Administration (FDA) laboratory analysis has found Lipofit Extreme Fat Burner 2.0 to

Content syndicated from the official FDA MedWatch Safety Alerts and Adverse Event Reporting Program.